The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system

Journal of Interferon and Cytokine Research

Volumn 18, Issue 6, 1998, Pages 415-421

  Okuda, Y ^a   Sakoda, S ^a   Bernard, C C A ^b   Yanagihara, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0031802920     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.415     Document Type: Article

References (36)

1. TSUKADA, I., and FUJINAMI, R.S. (1996). Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55, 673-686.
2. JACOBS, C.A., BAKER, P.E., ROUX, E.R., PICHA, K.S., TOIVOLA, B., WAUGH, S., and KENNEDY, M.K. (1991). Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146, 2983-2989.
3. DUONG, T.T., ST. LOUIS, J., GILBERT, J.J., FINKELMAN, F.D., and STREJAN, G.H. (1992). Effect of anti-interferon-γ and antiinterleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36, 105-115.
4. GIJBELS, K., BROCKE, S., ABRAMS, J.S., and STEINMAN, L. (1995). Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1, 795-805.
5. RUDDLE, N.H., BERGMAN, C.M., MCGRATH, K.M., LINGENHELD, E.G., GRUNNET, M.L., PADULA, S.J., and CLARK, R.B. (1990). An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
6. SELMAJ, K., RAINE, C.S., and CROSS, A.H. (1991). Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
7. RACKE, M.K., BONOMO, A., SCOTT, D.E., CANNELLA, B., LEVINE, A., RAINE, C.S., SHEVACH, E.M., and ROCKEN, M. (1994). Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
8. ROTT, O., FLEISCHER, B., and CASH, E. (1994). Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24, 1434-1440.
9. RACKE, M.K., JALBUT, S.D., CANNELLA, B., ALBERT, P.S., RAINE, C.S., and MCFARLIN, D.E. (1991). Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146, 3012-3017.
10. SANTAMBROGIO, L., HOCHWALD, G.M., SAXENA, B., LEU, C.H., MARTZ, J.E., CARLINO, J.A., RUDDLE, N.H., PALLADINO, M.A., GOLD, L.I., and THORBECKE, G.J. (1993). Studies on the mechanism by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 151, 1116-1127.
11. STEVENS, D.B., GOULD, K.E., and SWANBORG, R.H. (1994). Transforming growth factor-β1 inhibits tumor necrosis factor-α/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51, 77-83.
12. OKUDA, Y., NAKATSUJI, Y., FUJIMURA, H., ESUMI, H., OGURA, T., YANAGIHARA, T., and SAKODA, S. (1995). Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112.
13. WEINBERG, A.D., WALLIN, J.J., JONES, R.E., SULLIVAN, T.J., BOURDETTE, D.N., VANDENBARK, A.A., and OFFNER, H. (1994). Target organ-specific up-regulation of MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152, 4712-4721.
14. RENNO, T., LIN, J.Y., PICCIRILLO, C., ANTEL, J., and OWENS, T. (1994). Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49, 1-7.
15. RENNO, T., KRAKOWSKI, M., PICCIRILLO, C., LIN, J., and OWENS, T. (1995). TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J. Immunol. 154, 944-953.
16. KENNEDY, M.K., TORRANCE, D.S., PICHA, K.S., and MOHLER, K.M. (1992). Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149, 2496-2505.
17. ISSAZADEH, S., LIUNGDAHL, Å., HOJEBERG, B., MUSTAFA, M., and OLSSON, T. (1995). Cytokine production in the central nervous system of Lewis rat with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol. 61, 205-212.
18. ISSAZADEH, S., MUSTAFA, M., LIUNGDAHL, Å., HOJEBERG, B., DAGERLIND, Å., ELDE, R., and OLSSON, T. (1995). Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40, 579-590.
19. ISSAZADEH, S., LORENTZEN, J.C., MUSTAFA, M.I., HOJEBERG, B., MUSSENER, Å., and OLSSON, T. (1996). Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β. J. Neuroimmunol. 69, 103-115.
20. DIAB, A., ZHU, J., XIAO, B.G., MUSTAFA, M., and LINKS, H. (1997). High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J. Neuropathol. Exp. Neurol. 56, 641-650.
21. JOHNS, T.G., KERLERO DE ROSBO, N., MENSON, K., ABO, S., GONZALES, M.F., and BERNARD, C.C.A. (1995). Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154, 5536-5541.
22. BERNARD, C.C.A., JOHNS, T.G., SLAVIN, A., ICHIKAWA, M., EWING, C., LIU, J., and BETTADAPURA, J. (1997). Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75, 77-88.
23. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959.
24. ICHIKAWA, M., JOHNS, T.G., MARTIN, A., and BERNARD, C.C.A. (1996). Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int. Immunol. 8, 1667-1674.
25. BETTADAPURA, J., MENSON, K.K., MORITZ, S., LIU, J., and BERNARD, C.C.A. (1998). Expression, purification and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem. 70, 1593-1599.
26. KHOURY, S.J., HANCOCK, W.W., and WEINER, H.L. (1992). Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364.
27. CHEN, Y., KUCHROO, V.K., INOBE, J., HAFLER, D.A., and WEINER, H.L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
28. LIBLAU, R., STEINMAN, L., and BROCKE, S. (1997). Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol. 9, 799-803.
29. SELMAJ, K.W., and RAINE, C.S. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
30. VARTANIAN, T., LI, Y., ZHAO, M., and STEFANSSON, K. (1995). Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1, 732-743.
31. FERBER, I.A., BROCKE, S., EDWARDS, C.T., RIDGWAY, W., DINISCO, C., STEINMAN, L., DALTON, D., and FATHMAN, C.G. (1996). Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
32. WILLENBORG, D.O., FORDHAM, S., BERNARD, C.C.A., COWDEN, W.B., and RAMSHAW, I.A. (1996). IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227.
33. FREI, K., EUGSTER, H., BOPST, M., CONSTANTINESCU, C.S., LAVI, E., and FONTANA, A. (1997). Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 2177-2182.
34. LIU, J., MARINO M.W., WONG, G., GRAIL, D., DUNN, A., BETTADAPURA, J., SLAVIN, A.J., OLD, L., and BERNARD, C.C.A. (1998). TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med. 4, 78-83.
35. KÖRNER, H., RIMINTON, D.S., STRICKLAND, D.H., LEMSKERT, F.A., POLLARD, J.D., and SEDGWICK, J.D. (1997). Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186, 1585-1590.
36. SUEN, W.E., BERGMAN, C.M., HJELMSTRÖM, P., and RUDDLE, N.H. (1997). A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186, 1233-1240.